ClinicalTrials.Veeva

Menu

Ketamine Versus Haloperidol for Severe Agitation Outside the Hospital

Hennepin Healthcare logo

Hennepin Healthcare

Status and phase

Withdrawn
Phase 4

Conditions

Agitation

Treatments

Drug: Ketamine
Drug: Haloperidol

Study type

Interventional

Funder types

Other

Identifiers

NCT02103881
HSR #13-3682

Details and patient eligibility

About

This research study is being done to find out if one of two drugs, ketamine or haloperidol, is better for treating agitation. Agitation is a state of extreme emotional disturbance where patients can become physically aggressive or violent, endangering themselves and those who are caring for them. Often chemical substances or severe mental illness is involved in this level of agitation. Specifically, the investigators are interested in studying agitation that is treated in the prehospital setting by paramedics. This study's hypothesis is that ketamine is superior to haloperidol for treatment of agitation in the prehospital environment.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of severe agitation in the prehospital environment

Exclusion criteria

  • Prisoners
  • Persons known to be younger than 18 years old
  • Persons suspected to be younger than 18 years old
  • Obviously gravid women
  • Persons with profound agitation
  • Persons who are unable to be transported to the treating facility

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

0 participants in 2 patient groups

Ketamine
Experimental group
Description:
Patients enrolled in this arm will be given 500 mg of intramuscular ketamine for their severe agitation they experience in the prehospital environment.
Treatment:
Drug: Ketamine
Haloperidol
Experimental group
Description:
Patients enrolled in this arm will be given 10 mg of intramuscular haloperidol for their severe agitation they experience in the prehospital environment.
Treatment:
Drug: Haloperidol

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems